1. Yoga

Yoga combines slow movement, controlled breathing, and stillness. It’s a combination that can change how your body handles stress. A systematic review of yoga and stress found consistent evidence that regular practice lowers physiological stress markers, not just the feeling of being calmer. You don’t need an hour-long class for this to count. Even ten minutes of slow stretching and breathing before bed can help, and controlled breathing tends to matter more than how advanced any of the poses are.

2. Calming Music

Music is one of the easiest relaxation tools to use because it needs no planning and no equipment. A field study on music and cortisol found that listening to self-selected, calming music measurably reduced stress hormone levels compared with silence or noise. The key is picking something slower and quieter than your current mood, not louder or more upbeat. A lot of people instinctively reach for upbeat music to lift a bad mood, when something slower does more to bring your body out of a stressed state.

2. A Better Diet

What you eat earlier in the day affects how relaxed or wired you feel later on. NHS guidance on food and mood points to steady blood sugar, enough protein, and regular meals as practical and effective ways to avoid the irritability and low energy that make evenings feel harder than they need to be. Skipping meals and then feeling wired and snappy by 6pm is a common pattern, and it’s often mistaken for stress when it’s just low blood sugar catching up. This one works quietly in the background rather than giving an instant effect, but it adds up.

4. A Small Glass of Wine, in Moderation

For a lot of people, a drink is still the default way to relax at the end of the day, and there’s a real reason for that. Alcohol acts on the same GABA system described above, which is part of why it produces that loosened, social feeling. The UK Chief Medical Officers’ guidance, summarised by Drinkaware, recommends staying within 14 units a week, spread across several days, if you choose to drink at all. Within that guidance, an occasional glass can be part of how people unwind. It’s worth knowing, though, that alcohol’s other effects on the body are well documented, which is exactly why the next option exists.

5. Sentia, a Genuine Alcohol Alternative

Sentia is a range of GABA-enhancing functional drinks, built on ingredient technology developed by GABA Labs. The idea is straightforward: give people a drink that works through the same receptor system as alcohol, for that relaxed, social feeling we associate with those first few drinks, without the alcohol itself. Sentia is already available in the UK, US and EU, and it’s worth trying on nights you want to relax the side effects of alcohol. You can read more at sentiaspirits.com.

How Alcohol Switches On Your GABA Receptors

Ethanol, the active ingredient in alcoholic drinks, binds to GABA-A receptors and makes them more responsive, which increases the calming effect those receptors already produce. This is well established in the scientific literature. A widely cited review on GABA-A receptors and alcohol describes exactly how this binding drives the intoxication and relaxation effects most drinkers are familiar with. It’s a real, specific mechanism, not a vague “alcohol relaxes you” claim.

At lower doses, this is mostly what you notice, the loosened, sociable, slightly less inhibited feeling that makes a drink or two at the end of the week feel like a release. The receptor doesn’t distinguish between a small amount and a large one though, it just keeps responding as more ethanol arrives, which is part of why the effects of alcohol scale so directly with how much you drink.

Why Alcohol Doesn’t Stop There

Here’s the part that gets missed in most popular explanations. Ethanol is a very small molecule, and small molecules travel. Once it’s in your bloodstream, it doesn’t limit itself to GABA receptors. It reaches receptors and tissue throughout the body, and at those other sites, it doesn’t produce anything useful. It disrupts the functioning of several neurotransmitter systems (dopamine, serotonin, endorphin, noradrenaline, and glutamate). Alcohol is also metabolized (broken down) into several toxic byproducts, which is where the well documented health harms of alcohol come from. Alcohol Change UK’s overview of alcohol’s effect on organ health sets out how wide-ranging that damage can be, covering everything from the liver to the heart to the nervous system itself. So the honest version of the story is this: alcohol does one specific, useful thing very well, and then causes a lot of unrelated damage on its way through the rest of the body.

This is also why tolerance and dependence develop the way they do. Your brain, faced with ethanol repeatedly boosting dopamine activity, starts adjusting its own baseline to compensate, which is part of why regular drinkers need more alcohol over time and why stopping suddenly can feel so uncomfortable. None of that compensation is doing anything useful either. It’s the brain reacting to a molecule that shouldn’t be reaching most of the places it reaches.

Isolating the Good Chemistry: How GABA Labs’ Approach Works

This is the gap GABA Labs was set up to close. Rather than starting from ethanol and trying to make it safer, the approach starts from the GABA receptor itself and asks a different question: what would it take to produce that same relaxed, social effect, working through the same GABA receptor system, without using a molecule that spreads throughout the body causing harm along the way? As Professor David Nutt, GABA Labs’ co-founder and Chief Scientific Officer, puts it:

“Our goal is to develop new ways to deliver the social experience people value in alcohol, working through the same GABA receptor system as alcohol, but without alcohol; a genuine alcohol alternative, not a compromise.”

The scientific case for this approach is laid out in detail in Functional Alternatives to Alcohol, a peer-reviewed paper published in Nutrients in 2022 by Professor Nutt and colleagues, which sets out the evidence for targeting the GABA system directly as a route to a genuine alcohol alternative.

Why This Isn’t Just “Diet Alcohol”

It’s worth being clear about what this approach is not. It isn’t a weaker, watered-down version of alcohol, and it isn’t ethanol with the edges smoothed off. The whole point is that it doesn’t contain any alcohol at all. Working through the same receptor as alcohol means borrowing the one mechanism that actually produces the effect people want, while leaving out the molecule responsible for the harm.

1. Mechanism and target effect

Start with a clear, plausible mechanism tied to how alcohol works in the brain. Decades of research implicate the GABAergic system—particularly GABA-a and GABA-b receptors—as a primary mediator of alcohol’s behavioural and emotional effects. A robust alcohol‑alternative platform should explain:

• Which neural pathways or receptor systems it modulates.
• How this maps to specific consumer outcomes (e.g., calm, reduced social anxiety, easier wind‑down).
• Whether it engages broader brain–gut–microbiome signalling, an area of growing interest in alcohol research and functional alternatives

Ask suppliers to articulate the intended effect in consumer‑relevant language, backed by a mechanistic narrative that your regulatory and scientific affairs teams can scrutinise.

“At low doses, with blood alcohol concentrations of between 0.02% and 0.04%, the relaxing and sociability-promoting effects of alcohol are understood to be due to an enhancement of gamma-aminobutyric acid (GABA) activity in the brain. GABA is the main inhibitory neurotransmitter in the brain, and it is well-established that enhancing GABA function through the specific subtype of GABA-a receptors calms the brain through decreasing neuronal activity globally.”

— Professor David Nutt

2. Evidence base and regulatory posture

For high‑stakes innovation, “marketing story” is not enough. Expect a tiered evidence package:

• Peer‑reviewed preclinical data showing target engagement and behavioural relevance.
• Human data where possible (acute dosing, validated psychometric or behavioural endpoints).
• A safety dossier suitable for your key markets and a clear claims strategy.

GABA Labs’ own publications illustrate the type of foundational science you should look for, including reviews on functional alternatives to alcohol in Nutrients (2022) and The International Review of Neurobiology, and work on GABA signalling across the brain–gut–microbiome axis in Brain (2024) These provide a scaffold for understanding how nutritional and functional interventions might reproduce desirable alcohol effects with lower risk.

3. Sensory and formulation fit

Even a scientifically compelling ingredient will fail if it cannot be integrated into real formats. Require data on:

• Solubility and stability across pH, heat and light conditions typical of RTDs, beers, spirits and soft drinks.
• Flavour interactions and any need for masking or encapsulation.
• Dose‑to‑effect and dose‑to‑cost in realistic serve sizes (e.g., per 250–330 ml can or 50 ml spirit serve).

Your sensory and applications teams should be able to run rapid feasibility trials against clear performance targets (onset time, duration, perceived effect).

4. Safety, tolerability and consumer risk

Functional actives intended for regular social use must have a strong safety margin. Key questions:

• What human tolerability data exist at and above the intended dose?
• Are there known interactions with medications, caffeine or other common ingredients?
• Are there restrictions for specific populations (e.g., pregnant consumers, people with certain conditions)?

Aim for ingredients that support daily or frequent use, not just occasional “event” dosing, to align with habitual beverage occasions.

5. IP, licensing model and scale‑up

Finally, treat the ingredient as a strategic partnership. Clarify:

• IP ownership, territory exclusivity and potential for co‑development or co‑branding.
• Licensing terms, minimum volumes and roadmap for new formats or variants.
• Manufacturing capacity, quality certifications (e.g., ISO, FSSC22000) and supply chain resilience.

For global players, the ability to scale across regions and categories while maintaining consistent quality and regulatory status is non‑negotiable.

1. Mechanism and target effect

Start with mechanism. Alcohol’s effects are strongly linked to the GABAergic system, particularly GABA-a and GABA-b receptors, which is why many next-generation functional ingredients focus on GABA-related pathways. GABA Labs’ 2022 review explains how alcohol’s desirable pro-social effects are tied to the GABA system and how that knowledge can be used to develop functional safe alternatives to alcohol.

Ask:

• Is this a functional ingredient platform for beverages, or simply a nutrient-style input?
• Does the ingredient act through GABAergic signalling, gut-derived pathways or another mechanism?
• Is the intended effect relaxation, social ease, wind-down or something else?

If the supplier is positioning itself as a biomimetic GABAergic ingredient developer or functional alcohol-alternative ingredient partner, the mechanism should be clear enough for regulatory, scientific and product teams to evaluate.

2. Evidence and safety

For high-value beverage innovation, marketing claims are not enough. The supplier should be able to provide peer-reviewed data, human tolerability evidence where available, and a safety dossier that supports use in the intended markets.

A strong evidence package should include:

• Peer-reviewed preclinical or translational research.
• Human data, ideally with acute dosing and validated endpoints.
• Safety information at and above the intended dosage.
• A clear view of how the ingredient fits within GRAS, novel food or other relevant pathways.

This is especially important for teams evaluating a GABA ingredient supplier or a GABAergic ingredient B2B supplier, where the scientific rationale needs to support both formulation and regulatory conversations.

3. Regulatory pathway

Regulatory readiness can make or break a launch. Beverage manufacturers should ask whether the ingredient is suitable for the UK, EU and US, and whether the supplier can support market-specific approvals, claims substantiation and technical documentation.

For the United States, the key question is whether the ingredient can be positioned through the FDA GRAS process for use in conventional foods and beverages, or whether a different route is needed depending on intended use. Under FDA rules, a substance may be Generally Recognized as Safe (GRAS) through scientific procedures when there is sufficient publicly available evidence of safety for the intended conditions of use. The FDA has previously received a GRAS notice for GABA for use in beverages and other foods, which is relevant context for beverage manufacturers assessing U.S. launch pathways.

It is important to note that this GRAS reference relates to GABA as an ingredient class, not to Alcarelle specifically. Alcarelle has yet to complete the FDA GRAS process; its regulatory pathway is planned but not finalised as of the time of writing.

Useful questions include:

• Is the ingredient positioned as a novel food ingredient alcohol alternative UK/EU?
• Is there a GRAS route for the US?
• What documentation exists for formulation, use levels and intended beverage categories?
• Can the supplier support a licensing strategy in the UK or internationally?

For brands exploring how to license a functional beverage ingredient in the UK, the supplier should be able to explain the pathway clearly and without ambiguity. UK and EU low/no-alcohol labelling and regulatory guidance also matter because beverage categories and claims are tightly defined by market.

4. Stability, taste and dosage

Even the best science will fail if the ingredient is unstable or affects taste. Beverage manufacturers need a supplier that understands real-world formulation constraints across formats such as RTDs, canned cocktails, non-alcoholic beer and alcohol-free wine.

Ask for data on:

• Heat, light and pH stability.
• Solubility and suspension behaviour.
• Flavour neutrality or masking requirements.
• Effective dosage per serve.
• Impact on mouthfeel, aroma and finish.

This is particularly relevant for brands developing a GABA ingredient for RTD beverages, a functional ingredient for canned cocktails, or a functional ingredient for alcohol-free wine. The supplier should be able to show how the ingredient performs in a finished beverage, not just in a lab.

5. Commercial model and licensing support

The right supplier should be able to operate as an innovation partner, not just a raw material vendor. That means offering support for co-development, technical trials, licensing and, where relevant, white-label or own-brand opportunities.

Questions to ask:

• Can the supplier support co-development functional beverage ingredient projects?
• Is there a pathway to become a GABA Labs ingredient partner?
• Are white-label alcohol-alternative ingredient options available?
• What is the model for scale-up, exclusivity and territory rights?

For large manufacturers, this matters as much as the science. A supplier that can support a functional ingredient platform beverages strategy is more valuable than one-off ingredient access.